Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:39:09 GMT 2025
by
admin
on
Mon Mar 31 20:39:09 GMT 2025
|
| Protein Type | CYTOKINE |
| Protein Sub Type | Other|RECEPTOR-ANTAGONIST |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
9013DUQ28K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
L04AC03
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
65892
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
NDF-RT |
N0000175710
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
59991
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
636118
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
NCI_THESAURUS |
C1742
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
WHO-VATC |
QL04AC03
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
312110
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
488715
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
FDA ORPHAN DRUG |
745420
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
KINERET (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
NCI_THESAURUS |
C2486
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
NDF-RT |
N0000175709
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
||
|
LIVERTOX |
NBK548615
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB05500MIG
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201570
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
90470007
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
DB00026
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
DD-88
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
6972
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
9013DUQ28K
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
9013DUQ28K
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
ANAKINRA
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
100000085260
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
Anakinra
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
7137
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
72435
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | RxNorm | ||
|
m6315
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
5017
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
143090-92-0
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY | |||
|
C38717
Created by
admin on Mon Mar 31 20:39:09 GMT 2025 , Edited by admin on Mon Mar 31 20:39:09 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_67 | 1_117 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:SEQUENCE | CHEMICAL |
|
||||
| Biological Half-life | PHARMACOKINETIC |
|
|
|||